Lentiviral Gene Therapy Beneficial for Early Cerebral Adrenoleukodystrophy
No major functional disabilities observed at month 24; 81 percent of patients had no major functional disabilities at median of six years
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.